Economic Evaluation in Medicinal Product Development

Abstract Economic evaluation process in the medicinal product development is an essential and integrated element in the process continuum of the medicinal product’s performance evaluations. Ideally, economic evaluation processes would advance better cost-effectiveness analysis on the potential economic impacts of the medicinal product in terms of cost-burden and performance. Among the economic evaluation analysis processes, which includes cost-minimization analysis (CMA), cost-effectiveness analysis (CEA), cost-utility analysis (CUA), cost-benefit analysis (CBA), and cost-efficiency analysis; the appropriateness of the analysis in evaluating the medicinal product performance evaluation depends on a case-by-case scenario. For instance, with a “me-too” cost-performance evaluations, cost-effectiveness analysis is an essential evaluation process. However, the other economic evaluation processes are relevant to a “me-too” product assessment because the integration of all the evaluation processes would give a broader perspectives on the overall objectives on the impacts of the economic assessment of the “me-too” development processes. Economic Evaluation in Medicinal Product

This content is restricted to site members. If you are an existing user, please login. New users may register below.

Existing Users Log In